Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma.
暂无分享，去创建一个
A. Oza | J. Ledermann | E. Swisher | R. Coleman | C. Aghajanian | A. Leary | N. Colombo | G. Scambia | S. Goble | A. Clamp | R. Holloway | P. Fong | A. Oaknin | J. Weberpals | D. O’Malley | D. Lorusso | A. Dean | L. Maloney | T. Kwan | J. Goh | M. A. Gancedo | K. Lin